"Rags-To-Riches" Portfolio Update: Week Ending January 20, 2023

My new portfolio of 14 cannabis, psychedelic and plant-based food stocks were cumulatively pretty awful in 2022, thus could well offer high returns in 2023.

The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible and, after such massive declines, the market could well offer high returns to investors in 2023 and beyond and, to that end, I have created a basket of 14 stocks - aptly named the Rags-to-Riches Portfolio - for 2023 with market capitalizations of at least $400M, and trading for at least $1/share. Their performances last week and year-to-date are as follows:

  • American Cannabis MSOs:
    1. Cresco (CRLBF): Y/E 2022 Mkt. Cap.: $1.010M; Y/E Stock Price: $1.75; 2022 Performance: -73.8%
      • Last week: -0.5%; +11.4% YTD
    2. Curaleaf (CURLF): Y/E 2022 Mkt. Cap.:  $3,280M; Y/E Stock Price: $3.91; 2022 Performance: -73.8%
      • Last week: +1.5%; +3.8% YTD
    3. Green Thumb (GTBIF): Y/E 2022 Mkt. Cap.: $2,290M; Y/E Stock Price: $8.43; 2022 Performance: -62.0%
      • Last week: -3.6%; -5.1% YTD
    4. TerrAscend (TRSSF): Y/E 2022 Mkt. Cap.: $540M; Y/E Stock Price: $1.10 ; 2022 Performance: -82.0%
      • Last week: -9.3%; +23.6% YTD
    5. Trulieve (TCNNF): Y/E 2022 Mkt. Cap.: $1,770M; Y/E Stock Price: $7.56; 2022 Performance: -70.9%
      • Last week: -5.8%; -9.7% YTD
    6. Verano (VRNOF): Y/E 2022 Mkt. Cap.: $1,190M; Y/E Stock Price: $3.08 ; 2022 Performance: -75.5%
      • Last week: +2.0%; -0.6% YTD

Sub-total: Last week: -2.9%; -2.2% YTD

  • Canadian Cannabis LPs 
    1. Canopy Growth (CGC): Y/E 2022 Mkt. Cap.: $1,380M; Y/E Stock Price: $2.27; 2022 Performance: -74.0%
      • Last week: +0.4%; +15.0% YTD
    2. Cronos (CRON): Y/E 2022 Mkt. Cap: $1,060M; Y/E Stock Price: $2.52; 2022 Performance: -35.7%
      • Last week: -1.6%; -0.8% YTD 
    3. Tilray (TLRY): Y/E 2022 Mkt. Cap.: $2,070M; Y/E Stock Price: $2.67; 2022 Performance: -62.0%
      • Last week: -4.1%; +14.2% YTD

Sub-total: Last week: -1.9%; +9.4% YTD 

  • Psychedelic Drug Stocks
    1. Atai (ATAI): Y/E 2022 Mkt. Cap.: $500M; Y/E Stock Price: $2.58; 2022 Performance: -66.2%
      • Last week: +5.6%; -26.4% YTD
    2. Compass Pathways (CMPS): Y/E 2022 Mkt. Cap.: $402M; Y/E Stock Price: $7.81; 2022 Performance: -64.7%
      • Last week: +3.6%; +26.5% YTD
    3. GH Research (GHRS): Y/E 2022 Mkt. Cap.: $611M; Y/E Stock Price: $9.54; 2022 Performance: -59.1%  
      • Last week: +1.3%; +2.6% YTD

Sub-total: Last week: +2.7%; +8.2% YTD

  • Plant-Based Food Stocks 
    1. Beyond Meat (BYND): Y/E 2022 Mkt. Cap.: $805M; Y/E Stock Price: $12.29; 2022 Performance: -80.8%
      • Last week: -5.1%; +23.0% YTD
    2. Oatly Group (OTLY): Y/E 2022 Mkt. Cap.: $1,210M; Y/E Stock Price: $1.74; 2022 Performance: -78.1%
      • Last week: +0.8%; +46.0% YTD

Sub-total: Last week: -4.3%; +25.9% YTD

Grand Total:

  • Portfolio Performance Last Week: -1.5%; YTD: +8.0%

In comparison, the A Potential "Multi-bagger" Portfolio of 10 stocks with market capitalizations between US$100M and US$399M  was DOWN 3.5% last week but is still UP 16.5% YTD.


More By This Author:

Largest Psychedelic Stocks +3% This Week; Now +15% YTD
Largest American Cannabis MSOs -3% This Week; Now Only +0.6% YTD
Largest Cannabis LPs -2% This Week; +10.5% YTD

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample here).

STOCKS IN THIS ARTICLE

Comments